ABSTRACT
Purpose To investigate if body composition is a biomarker for assessing the risk of developing lung cancer.
Materials and Methods Low-dose computed tomography (LDCT) scans from the Pittsburgh Lung Screening Study (PLuSS) (n=3,635, 22 follow-up years) and NLST-ACRIN (n=16,435, 8 follow-up years) cohorts were used in the study. Artificial intelligence (AI) algorithms were developed to automatically segment and quantify subcutaneous adipose tissue (SAT), visceral adipose tissue (VAT), intramuscular adipose tissue (IMAT), skeletal muscle (SM), and bone. Cause-specific Cox proportional hazards models were used to evaluate the hazard ratios (HRs). Standard time-dependent receiver operating characteristic (ROC) analysis was used to evaluate the prognostic ability of different models over time.
Results The final composite models were formed by seven variables: age (HR=1.20), current smoking status (HR=1.59), bone volume (HR=1.79), SM density (HR=0.29), IMAT ratio (HR=0.33), IMAT density (HR=0.56), and SAT volume (HR=0.56). The models trained on the PLuSS cohort achieved a mean AUC of 0.76 (95% CI: 0.74-0.79) over 21 follow-up years and 0.70 (95% CI: 0.66-0.74) over the first 7 follow-up years for predicting lung cancer development within the PLuSS cohort. In contrast, models trained on the PLuSS cohort alone, as well as in combination with the NLST cohorts, achieved an AUC ranging from 0.61 to 0.68 in the NLST cohort over a 7-year follow-up period.
Conclusion Body composition assessed on LDCT is a significant predictor of lung cancer risk and could improve the effectiveness of LDCT lung cancer screening by optimizing the screening eligibility and frequency.
Summary statement Body composition assessed on LDCT is a significant predictor of lung cancer risk and could improve the effectiveness of LDCT lung cancer screening by optimizing the screening eligibility and frequency.
Key Points
This study unveils the significant associations between body tissues and lung cancer risk.
The prediction models based on body composition alone, as well as the combination of demographics and body composition features can effectively identify patients at higher risk of developing lung cancer.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work is supported in part by research grants from the National Institutes of Health (NIH) (R01CA237277, U01CA271888, and P30CA047904) and UPMC Hillman Developmental Pilot Program.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The University of Pittsburgh Institutional Review Board (IRB 21020128) gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Abbreviations
- AI
- artificial intelligence
- ACRIN
- American College of Radiology Imaging Network
- AUC
- area under curve
- BMI
- body mass index
- CI
- confidence interval
- FOV
- field-of-view
- HR
- hazard ratio
- IMAT
- intramuscular adipose tissue
- LDCT
- low-dose computed tomography
- PLuSS
- Pittsburgh Lung Screening Study
- NLST
- National Lung Screening Trial
- ROC
- receiver operating characteristic
- SAT
- subcutaneous adipose tissue
- SM
- skeletal muscle
- VAT
- visceral adipose tissue